BioElectronics Corporation (BIEL)
OTCMKTS · Delayed Price · Currency is USD
0.0003
+0.0001 (50.00%)
Jul 31, 2026, 2:41 PM EST
BioElectronics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
Period Ending | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Cash & Equivalents | 0 | 0.11 | 0.05 | 0.09 | 0.01 |
Cash & Short-Term Investments | 0 | 0.11 | 0.05 | 0.09 | 0.01 |
Cash Growth | -99.16% | 137.28% | -50.28% | 944.59% | 54.03% |
Receivables | 0.06 | 0.16 | 0.19 | 0.06 | 0.02 |
Inventory | 0.03 | 0.15 | 0.1 | 0.29 | 0.44 |
Other Current Assets | - | - | 0.01 | 0.02 | 0.03 |
Total Current Assets | 0.08 | 0.43 | 0.34 | 0.47 | 0.5 |
Property, Plant & Equipment | - | - | - | 0 | 0 |
Total Assets | 0.08 | 0.43 | 0.34 | 0.47 | 0.5 |
Liabilities
Fiscal Year | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
Period Ending | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Accounts Payable | 0.65 | 0.73 | 1.82 | 0.96 | 0.95 |
Accrued Expenses | 0.63 | 0.63 | - | - | - |
Short-Term Debt | - | - | 0.12 | - | - |
Current Portion of Long-Term Debt | 4.07 | 6.47 | 7.04 | 7.31 | 4.62 |
Current Unearned Revenue | 0.09 | 0.54 | 0.3 | 0.54 | 0.03 |
Other Current Liabilities | 0.48 | 0.46 | - | - | - |
Total Current Liabilities | 5.93 | 8.84 | 9.28 | 8.8 | 5.59 |
Long-Term Debt | 9.27 | 6.7 | 5.64 | 4.69 | 5.59 |
Total Liabilities | 15.2 | 15.55 | 14.92 | 13.49 | 11.19 |
Shareholders' Equity
Fiscal Year | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
Period Ending | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Common Stock | 24.38 | 24.13 | 22.92 | 20.71 | 18.99 |
Additional Paid-In Capital | - | - | - | 1.03 | 2.1 |
Retained Earnings | -38.31 | -38.25 | -37.09 | -34.76 | -31.77 |
Comprehensive Income & Other | -1.19 | -1.01 | -0.41 | - | - |
Shareholders' Equity | -15.12 | -15.12 | -14.57 | -13.02 | -10.68 |
Total Liabilities & Equity | 0.08 | 0.43 | 0.34 | 0.47 | 0.5 |
Additional Metrics
Fiscal Year | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
Period Ending | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Total Debt | 13.34 | 13.18 | 12.8 | 12 | 10.21 |
Net Cash (Debt) | -13.34 | -13.07 | -12.75 | -11.91 | -10.2 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Filing Date Shares Outstanding | 24,379 | 24,672 | 22,918 | 20,706 | 18,992 |
Total Common Shares Outstanding | 24,379 | 24,672 | 22,918 | 20,706 | 18,992 |
Working Capital | -5.85 | -8.42 | -8.94 | -8.34 | -5.09 |
Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Tangible Book Value | -15.12 | -15.12 | -14.57 | -13.02 | -10.68 |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Machinery | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
Leasehold Improvements | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |